Skip to main content


Fig. 6 | Cancer Nanotechnology

Fig. 6

From: A [60]fullerene nanoconjugate with gemcitabine: synthesis, biophysical properties and biological evaluation for treating pancreatic cancer

Fig. 6

Evaluation of the induction of apoptosis in the PAN02 cell line after a 48-h treatment with nanoC60GEM (35 and 17 µM) and GEM (1.5 and 0.75 µM). The histograms show the percentage of early and late apoptosis for one of the experiments (a). The table shows the mean ± SD percentage of the live, early and late apoptotic cells from three independent experiments (b). The data were analyzed using one-way ANOVA with a Bonferroni’s post hoc test: *p < 0.05, **p < 0.01, ***p < 0.001 compared to the control (c)

Back to article page